Literature DB >> 12544878

Mortality rates after heart transplantation: how to compare center-specific outcome data?

J M A Smits1, J De Meester, M C Deng, H H Scheld, M Hummel, F Schoendube, A Haverich, J Vanhaecke, H C van Houwelingen.   

Abstract

BACKGROUND: Studies of outcome in cardiac transplantation have focused primarily on identifying patient- and donor-related factors associated with patient mortality. Less consideration has been given to the impact of the transplant center. This study was undertaken to assess variability in heart transplantation outcome in Eurotransplant centers to provide a framework for auditing. METHODS AND
RESULTS: In a 2-year period, 1,401 adult patients underwent heart transplantation in 45 centers. The 1-year patient survival rate was 76% (95% CI, 74%-78%) with a range of 0% to 100% at the center level. The risk-adjusted center effect on mortality was estimated by calculating a standardized difference between the observed number of deaths 1 year after transplantation and the expected number of deaths based on the case mix. By assessing within- and between-center variations with empirical Bayes (EB) methods, after adjustment for all registered prognostic factors, an improved estimate of the true center effect was obtained. Compared with the standard risk-adjusted center effect method, fewer outlying centers were identified with the EB method.
CONCLUSION: EB methods, because they are known to incorporate more information from the data, enable a more precise and realistic portrayal of heart transplant centers' performances, compared with other risk-adjusted center effect methods. In the context of auditing procedures, EB methods should preferably be used for the identification of centers that deviate significantly from quality standards.

Entities:  

Mesh:

Year:  2003        PMID: 12544878     DOI: 10.1097/00007890-200301150-00017

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Progenitor cells isolated from the human heart: a potential cell source for regenerative therapy.

Authors:  P van Vliet; M Roccio; A M Smits; A A M van Oorschot; C H G Metz; T A B van Veen; J P G Sluijter; P A Doevendans; M-J Goumans
Journal:  Neth Heart J       Date:  2008-05       Impact factor: 2.380

2.  A Five-Tier System for Improving the Categorization of Transplant Program Performance.

Authors:  Andrew Wey; Nicholas Salkowski; Bertram L Kasiske; Ajay K Israni; Jon J Snyder
Journal:  Health Serv Res       Date:  2017-06-13       Impact factor: 3.402

3.  Comparing and ranking hospitals based on outcome: results from The Netherlands Stroke Survey.

Authors:  H F Lingsma; E W Steyerberg; M J C Eijkemans; D W J Dippel; W J M Scholte Op Reimer; H C Van Houwelingen
Journal:  QJM       Date:  2009-12-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.